PREVALENCE OF DIFFERENT MENSTRUAL IRREGULARITIES IN WOMEN WITH ABNORMAL UTERINE BLEEDING(AUB) - AN OBSERVATIONAL STUDY -
article
OA: closed
CC0
⤵ 4 in-corpus citations
AI-generated summary
This observational study found menorrhagia to be the most prevalent menstrual irregularity among 1362 women diagnosed with abnormal uterine bleeding.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Introduction: Abnormal Uterine Bleeding (AUB) is a term which refers to menstrual bleeding of abnormal frequency, duration or quantity. It is a common gynecological complaint accounting one third of outpatient visits to gynecologist. Abnormal Uterine Bleeding includes Oligomenorrhoea, Polymenorrhoea, Hypomenorrhoea, Menorrhagia, Metrorrhagia and Dysfunctional Uterine Bleeding. This paper elicits the prevalence of different menstrual disorders among women with Abnormal Uterine Bleeding. Objective: To observe the prevalence of different menstrual irregularities in patients with Abnormal Uterine Bleeding. Methodology: The study was carried out in the Gynaec out Patient Department of National Institute Unani Medicine Hospital during the years of 2014–2015.Total 1362 patients of Abnormal Uterine Bleeding were included in the study on basis of clinical sign and symptoms and history. Results: Among 7471 Gynaec patients 1362 (18.23%) patients were found with Abnormal Uterine Bleeding (AUB) and out of 1362 patients of Abnormal Uterine Bleeding highest were with menorrhagia i.e. 450 (33%) and least were with hypomenorrhoea i.e. 162 (11.89%). Prevalence of menorrhagia was highest between the ages of 25-34 years. Conclusion: It is concluded that the prevalence of menorrhagia is high among all Abnormal Uterine Bleeding and it affects woman health status, quality of life and social integration. It is suggested that menstrual complaints should be thoroughly evalu- ated and treated on a top priority.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- Financial and Quality-of-Life Burden of Dysfunctional Uterine Bleeding Among Women Agreeing To Obtain Surgical Treatment 2008
- Treating Menorrhagia in Primary Care: <i>An Overview of Drug Trials and a Survey of Prescribing Practice</i> 1995
Cited by (4)
- Clinical pattern and presentation of abnormal uterine bleeding 2019
- Abnormal Uterine Bleeding: Comparison of Transabdominal and Transvaginal Sonography 2024
- Is Metabolic Syndrome a Fellow Traveler with Abnormal Uterine Bleeding in Women of Reproductive Age? A Case–Control Study 2023
- Diagnostic accuracy of saline infusion sonography as compared to hysteroscopy in premenopausal women with abnormal uterine bleeding 2019
References (20)
- Financial and Quality-of-Life Burden of Dysfunctional Uterine Bleeding Among Women Agreeing To Obtain Surgical Treatment via openalex
- Treating Menorrhagia in Primary Care: <i>An Overview of Drug Trials and a Survey of Prescribing Practice</i> via openalex
- W1972176076 via openalex
- W2008015311 via openalex
- W2010559171 via openalex
- W2012165536 via openalex
- W2025064905 via openalex
- W2029440741 via openalex
- W2055381245 via openalex
- W2065298721 via openalex
- W2074648622 via openalex
- W2088973845 via openalex
- W2098230593 via openalex
- W2116501728 via openalex
- W2146639820 via openalex
- W2277610121 via openalex
- W2408355554 via openalex
- W91271133 via openalex
- W2419391034 via openalex
- W1194402859 via openalex
Cited by (4)
- Abnormal Uterine Bleeding: Comparison of Transabdominal and Transvaginal Sonography 2024
- Is Metabolic Syndrome a Fellow Traveler with Abnormal Uterine Bleeding in Women of Reproductive Age? A Case–Control Study 2023
- Clinical pattern and presentation of abnormal uterine bleeding 2019
- Diagnostic accuracy of saline infusion sonography as compared to hysteroscopy in premenopausal women with abnormal uterine bleeding 2019
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK